What is a partitioned survival model?

What is a partitioned survival model?

What is a Cox regression model?

What is a Cox regression model?

Market access and reimbursement in Canada – changes at CADTH

Market access and reimbursement in Canada – changes at CADTH

What is a discrete event simulation in health economics?

What is a discrete event simulation in health economics?

What is the vision for primary care provider collaboratives in the NHS?

What is the vision for primary care provider collaboratives in the NHS?

What is a Markov model? - Health economics model structures

What is a Markov model? - Health economics model structures

3 challenges your proposal must address for NHS decision-makers

3 challenges your proposal must address for NHS decision-makers

Rare Disease market access in the MENA and Nordic regions

Rare Disease market access in the MENA and Nordic regions

What is a decision tree and how is it used in health economics?

What is a decision tree and how is it used in health economics?

Does your medical device or diagnostic empower patients?

Does your medical device or diagnostic empower patients?

Optimising NHS funding decisions: focusing on outcomes and ROI

Optimising NHS funding decisions: focusing on outcomes and ROI

Opportunities to support secondary care in the NHS

Opportunities to support secondary care in the NHS

Introducing Mtech Access - Leaders in Global Pharma and Medtech Commercialisation

Introducing Mtech Access - Leaders in Global Pharma and Medtech Commercialisation

Health economic evaluation for HTA in different markets

Health economic evaluation for HTA in different markets

How does funding flow in NHSE Regions?

How does funding flow in NHSE Regions?

NHS policy for 2024/25: strategy and engagement in a world of uncertainty

NHS policy for 2024/25: strategy and engagement in a world of uncertainty

Get payer input and feedback on your evidence strategy early

Get payer input and feedback on your evidence strategy early

De-mystifying health economic model classifications and structures

De-mystifying health economic model classifications and structures

Is it worth investing time to launch in NHS Wales?

Is it worth investing time to launch in NHS Wales?

How does specialised commissioning work in Wales?

How does specialised commissioning work in Wales?

6 key early decisions when launching new Pharma and Medtech products

6 key early decisions when launching new Pharma and Medtech products

What would the NHS in Wales want to see from an industry partner?

What would the NHS in Wales want to see from an industry partner?

Evidence strategy for Medical Technologies and Diagnostics

Evidence strategy for Medical Technologies and Diagnostics

What is changing for Pharma and Medtech industries in the US?

What is changing for Pharma and Medtech industries in the US?

How should Pharma respond to the changes to NHS specialised services?

How should Pharma respond to the changes to NHS specialised services?

How is the NHS tackling workforce challenges in Wales

How is the NHS tackling workforce challenges in Wales

How does funding flow in NHS Wales?

How does funding flow in NHS Wales?

How to set your Pharma or Medtech product up for success in the US market

How to set your Pharma or Medtech product up for success in the US market

Where will budgets sit for specialised services in the NHS?

Where will budgets sit for specialised services in the NHS?

How can industry best engage with the NHS in Wales?

How can industry best engage with the NHS in Wales?